Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...AstraZeneca has promised to increase its dividend by 7 per cent this year, ahead of a key shareholder vote on pay for its long-standing chief executive Pascal Soriot....
Admonitions about staff trading in their employer’s shares may now need to be broadened
...He added that Emblaveo’s pricing “will be a key question since some of the resistant bacteria it targets are most prevalent in low- and middle-income countries”....
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
...It had been struggling to keep up because of a lack of resources after the UK left the EU, where it had been a key part of the bloc’s regulatory agency....
...Part way through her 23-year-old son’s chemotherapy, Kristin Caparra was told that one of the drugs key to his treatment — methotrexate — was running out....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...Since leaving the European Union in January 2020, the UK has faced “constantly elevated medicines shortages” including for key treatments such as antibiotics and epilepsy drugs, the think-tank said on Thursday...
...On Tuesday, it also disclosed that bonus payments to staff were cut by €1.4bn last year after key performance targets were missed....
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...Anderson during the interview said a key argument against a capital increase was how dilutive it would be to existing investors. “I’m a shareholder too, and I don’t want that.”...
...Most big pharmaceutical and medtech companies have operations in the country, which produces some 40 per cent of the world’s contact lenses, as well as all the world’s Botox and a key ingredient used in...
...Many biotechs hoping to enter the market will aim for partnerships with larger groups, a well-trodden path in the pharmaceutical industry....
...Florida has estimated that it could save up to $150mn a year by importing key medicines for treating diabetes, infectious diseases such as HIV and hepatitis C, and mental health conditions....
...It also sold off the Vaccine Manufacturing and Innovation Centre, billed as a key piece of preparedness infrastructure, in 2022. Consistency matters....
International Edition